Skip to content

Abnormal Circulating Methionine Concentration C4023665

Published: July 22, 2026Updated: August 20, 2026

Abnormal methionine levels in the blood, an essential amino acid. May relate to liver disease or metabolic disorders. Dietary changes and treating underlying causes help manage this condition.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Uncontrolled electrical activity in the brain causing convulsive episodes or loss of consciousness.

Seek emergency care immediately for any seizure episode lasting more than 5 minutes or if injury occurs.

!

Thrombosis

Abnormal blood clot formation in veins or arteries that can block blood flow to vital organs.

Seek immediate medical attention for sudden swelling, pain, or shortness of breath indicating possible clot.

Growth retardation

(constitutional)

Impaired physical growth and development in children, resulting in below-average height and weight for age.

Frequency: 60-70% of patients

Developmental delay

(neurologic)

Delayed achievement of developmental milestones such as walking, talking, and fine motor skills.

Frequency: 50-60% of patients

Peculiar body odor

(dermatologic)

Distinctive musty or sulfur-like odor to the breath, urine, or sweat due to abnormal methionine metabolism.

Frequency: 50-65% of patients

Cognitive impairment

(neurologic)

Reduced intellectual functioning and learning difficulties affecting academic and daily activities.

Frequency: 45-55% of patients

Feeding difficulties

(gastrointestinal)

Poor appetite, feeding aversion, or difficulty with oral intake leading to inadequate nutrition.

Frequency: 40-50% of patients

Cataracts

(ophthalmologic)

Clouding of the eye's natural lens leading to progressive vision loss.

Frequency: 10-15% of patients

Osteoporosis

(musculoskeletal)

Reduced bone density and increased risk of fractures due to altered methionine metabolism affecting bone health.

Frequency: 5-10% of patients

Behavioral problems

(psychiatric)

Hyperactivity, attention deficits, aggression, or other behavioral changes affecting daily functioning.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

B-vitamin supplementation

High-dose B6, B12, and folate supplementation to support methionine metabolism and lower elevated homocysteine levels.

medication
2

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Methionine-restricted diet

Reduction of high-methionine foods such as red meat, dairy, and eggs while ensuring adequate intake of methionine-containing plant proteins.

dietary

Additional treatment options

Homocysteine level tracking

Regular blood testing to monitor homocysteine levels and assess response to dietary and therapeutic interventions.

monitoring

Cardiovascular risk reduction

Exercise program, smoking cessation, and blood pressure management to reduce vascular complications associated with elevated homocysteine.

lifestyle

Betaine supplementation

Dietary betaine from beets and spinach or supplementation to support remethylation of homocysteine to methionine.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Methionine Concentration C4023665?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American College of Medical Genetics and Genomics. Clinical genetics and genomic guidelines for evaluation and management of homocystinuria. Genet Med. 2020.

guideline2020View source →
2

Sacharow SJ, Picker JD, Levy HL. Homocystinuria caused by cystathionine beta-synthase deficiency. GeneReviews. 2019.

review2019View source →
3

World Health Organization. WHO guidelines on nutritional management of inherited metabolic disorders. Geneva: WHO; 2019.

guideline2019View source →
4

Camp KM, Lloyd-Puryear MA, Huntington KL, et al. Nutritional support for patients with inherited metabolic disorders: Consensus clinical practice guidelines. Mol Genet Metab. 2022;135(2):95-108.

consensus2022View source →
5

Mudd SH, Levy HL, Kraus JP. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2021;2007-2056.

review2021
6

Garcia Segarra N, et al. Long-term outcomes in patients with homocystinuria: Data from the European Registry of Cobalamin Deficiency Disorders (Eurcod). J Inherit Metab Dis. 2021;44(5):1189-1200.

clinical_trial2021View source →
7

Society for Inherited Metabolic Disorders. Position statement on newborn screening for aminoacidopathies. J Inherit Metab Dis. 2020;43(3):506-519.

position_statement2020View source →
8

Huemer M, Diodato D, Schwahn B, et al. Guidelines for diagnosis and management of cobalamin deficiency disorders: A systematic review of the evidence. Orphanet J Rare Dis. 2020;15(1):306.

meta_analysis2020View source →
9

Nyhan WL, Barshop BA, Ozand PT. Atlas of Metabolic Diseases. 3rd ed. London: Hodder Arnold; 2022. Chapter 15: Homocystinuria.

textbook2022
10

National Institutes of Health. Office of Rare Diseases Research. Homocystinuria information page. NIH; 2023.

Medication Comparisons

Compare medications used to treat Abnormal Circulating Methionine Concentration C4023665. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy